vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and NCR Atleos Corp (NATL). Click either name above to swap in a different company.
NCR Atleos Corp is the larger business by last-quarter revenue ($1.2B vs $829.0M, roughly 1.4× Acadia Healthcare Company, Inc.). NCR Atleos Corp runs the higher net margin — 7.2% vs 0.5%, a 6.7% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 4.0%). Over the past eight quarters, NCR Atleos Corp's revenue compounded faster (4.9% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
NCR Voyix Corporation, previously known as NCR Corporation and National Cash Register, is a global software, consulting and technology company providing several professional services and electronic products. It manufactured self-service kiosks, point-of-sale terminals, automated teller machines, check processing systems, and barcode scanners.
ACHC vs NATL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $829.0M | $1.2B |
| Net Profit | $4.5M | $83.0M |
| Gross Margin | — | — |
| Operating Margin | — | 13.5% |
| Net Margin | 0.5% | 7.2% |
| Revenue YoY | 7.5% | 4.0% |
| Net Profit YoY | -50.8% | 102.4% |
| EPS (diluted) | $0.05 | $1.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.2B | ||
| Q3 25 | $851.6M | $1.1B | ||
| Q2 25 | $869.2M | $1.1B | ||
| Q1 25 | $770.5M | $979.0M | ||
| Q4 24 | $774.2M | $1.1B | ||
| Q3 24 | $815.6M | $1.1B | ||
| Q2 24 | $796.0M | $1.1B |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $83.0M | ||
| Q3 25 | $36.2M | $26.0M | ||
| Q2 25 | $30.1M | $39.0M | ||
| Q1 25 | $8.4M | $14.0M | ||
| Q4 24 | $32.6M | $41.0M | ||
| Q3 24 | $68.1M | $21.0M | ||
| Q2 24 | $78.5M | $27.0M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 13.5% | ||
| Q3 25 | 4.7% | 9.8% | ||
| Q2 25 | 5.8% | 10.8% | ||
| Q1 25 | 1.7% | 9.5% | ||
| Q4 24 | 4.9% | 13.4% | ||
| Q3 24 | 12.1% | 10.6% | ||
| Q2 24 | 13.4% | 9.8% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 7.2% | ||
| Q3 25 | 4.3% | 2.3% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 1.1% | 1.4% | ||
| Q4 24 | 4.2% | 3.7% | ||
| Q3 24 | 8.4% | 2.0% | ||
| Q2 24 | 9.9% | 2.5% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.09 | ||
| Q3 25 | $0.40 | $0.34 | ||
| Q2 25 | $0.33 | $0.52 | ||
| Q1 25 | $0.09 | $0.19 | ||
| Q4 24 | $0.36 | $0.56 | ||
| Q3 24 | $0.74 | $0.28 | ||
| Q2 24 | $0.85 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $456.0M |
| Total DebtLower is stronger | $2.5B | $2.7B |
| Stockholders' EquityBook value | $2.0B | $403.0M |
| Total Assets | $5.5B | $5.7B |
| Debt / EquityLower = less leverage | 1.29× | 6.63× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $456.0M | ||
| Q3 25 | $118.7M | $412.0M | ||
| Q2 25 | $131.4M | $357.0M | ||
| Q1 25 | $91.2M | $352.0M | ||
| Q4 24 | $76.3M | $419.0M | ||
| Q3 24 | $82.1M | $395.0M | ||
| Q2 24 | $77.2M | $374.0M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $2.7B | ||
| Q3 25 | $2.3B | $2.8B | ||
| Q2 25 | $2.3B | $2.8B | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | $2.9B | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $403.0M | ||
| Q3 25 | $3.1B | $330.0M | ||
| Q2 25 | $3.1B | $350.0M | ||
| Q1 25 | $3.0B | $275.0M | ||
| Q4 24 | $3.1B | $219.0M | ||
| Q3 24 | $3.0B | $264.0M | ||
| Q2 24 | $3.0B | $250.0M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $5.7B | ||
| Q3 25 | $6.4B | $5.7B | ||
| Q2 25 | $6.3B | $5.8B | ||
| Q1 25 | $6.1B | $5.7B | ||
| Q4 24 | $6.0B | $5.5B | ||
| Q3 24 | $5.9B | $5.7B | ||
| Q2 24 | $5.7B | $5.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 6.63× | ||
| Q3 25 | 0.74× | 8.45× | ||
| Q2 25 | 0.74× | 8.05× | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | 13.05× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $231.0M |
| Free Cash FlowOCF − Capex | — | $194.0M |
| FCF MarginFCF / Revenue | — | 16.8% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | 13.78× | 2.78× |
| TTM Free Cash FlowTrailing 4 quarters | — | $239.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $231.0M | ||
| Q3 25 | $73.2M | $25.0M | ||
| Q2 25 | $133.5M | $-23.0M | ||
| Q1 25 | $11.5M | $123.0M | ||
| Q4 24 | $116.7M | $80.0M | ||
| Q3 24 | $163.1M | $107.0M | ||
| Q2 24 | $171.1M | $9.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $194.0M | ||
| Q3 25 | $-63.0M | $-5.0M | ||
| Q2 25 | $-34.2M | $-44.0M | ||
| Q1 25 | $-163.2M | $94.0M | ||
| Q4 24 | $-86.8M | $62.0M | ||
| Q3 24 | $-27.1M | $85.0M | ||
| Q2 24 | $16.9M | $-14.0M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 16.8% | ||
| Q3 25 | -7.4% | -0.4% | ||
| Q2 25 | -3.9% | -4.0% | ||
| Q1 25 | -21.2% | 9.6% | ||
| Q4 24 | -11.2% | 5.6% | ||
| Q3 24 | -3.3% | 7.9% | ||
| Q2 24 | 2.1% | -1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.2% | ||
| Q3 25 | 16.0% | 2.7% | ||
| Q2 25 | 19.3% | 1.9% | ||
| Q1 25 | 22.7% | 3.0% | ||
| Q4 24 | 26.3% | 1.6% | ||
| Q3 24 | 23.3% | 2.1% | ||
| Q2 24 | 19.4% | 2.1% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.78× | ||
| Q3 25 | 2.02× | 0.96× | ||
| Q2 25 | 4.43× | -0.59× | ||
| Q1 25 | 1.37× | 8.79× | ||
| Q4 24 | 3.58× | 1.95× | ||
| Q3 24 | 2.39× | 5.10× | ||
| Q2 24 | 2.18× | 0.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
NATL
| Services | $848.0M | 74% |
| APJ | $136.0M | 12% |
| Americas Excluding United States | $135.0M | 12% |
| TT | $44.0M | 4% |